Oestrogen receptor-independent actions of oestrogen in cancer.

Mol Biol Rep

Department of Molecular Oncology, Cancer Institute (WIA), Adyar, Chennai, 600020, India.

Published: November 2023

Oestrogen, the primary female sex hormone, plays a significant role in tumourigenesis. The major pathway for oestrogen is via binding to its receptor [oestrogen receptor (ERα or β)], followed by nuclear translocation and transcriptional regulation of target genes. Almost 70% of breast tumours are ER + , and endocrine therapies with selective ER modulators (tamoxifen) have been successfully applied. As many as 25% of tamoxifen-treated patients experience disease relapse within 5 years upon completion of chemotherapy. In such cases, the ER-independent oestrogen actions provide a plausible explanation for the resistance, as well as expands the existing horizon of available drug targets. ER-independent oestrogen signalling occurs via one of the following pathways: signalling through membrane receptors, oxidative catabolism giving rise to genotoxic metabolites, effects on mitochondria and redox balance, and induction of inflammatory cytokines. The current review focuses on the non-classical oestrogen signalling, its role in cancer, and its clinical significance.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-023-08793-8DOI Listing

Publication Analysis

Top Keywords

er-independent oestrogen
8
oestrogen signalling
8
oestrogen
7
oestrogen receptor-independent
4
receptor-independent actions
4
actions oestrogen
4
oestrogen cancer
4
cancer oestrogen
4
oestrogen primary
4
primary female
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!